Fennec Pharmaceuticals Inc (FENC)
9.28
+0.12
(+1.31%)
USD |
NASDAQ |
Apr 26, 13:49
Fennec Pharmaceuticals Cash from Financing (TTM): 6.638M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.638M |
September 30, 2023 | 1.732M |
June 30, 2023 | 21.38M |
March 31, 2023 | 20.91M |
December 31, 2022 | 20.73M |
September 30, 2022 | 19.92M |
June 30, 2022 | 0.071M |
March 31, 2022 | 4.993M |
December 31, 2021 | 4.978M |
September 30, 2021 | 5.43M |
June 30, 2021 | 5.313M |
March 31, 2021 | 32.29M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -0.071M |
September 30, 2019 | 1.116M |
June 30, 2019 | 1.599M |
March 31, 2019 | 2.09M |
December 31, 2018 | 2.347M |
September 30, 2018 | 21.05M |
June 30, 2018 | 20.98M |
March 31, 2018 | 28.16M |
December 31, 2017 | 27.98M |
Date | Value |
---|---|
September 30, 2017 | 8.083M |
June 30, 2017 | 7.669M |
March 31, 2017 | 5.006M |
December 31, 2016 | 5.108M |
September 30, 2016 | 5.108M |
June 30, 2016 | 5.129M |
March 31, 2016 | 0.572M |
December 31, 2015 | 0.497M |
September 30, 2015 | 2.679M |
June 30, 2015 | 2.679M |
March 31, 2015 | 2.317M |
December 31, 2014 | 2.343M |
September 30, 2014 | 1.731M |
June 30, 2014 | 1.71M |
March 31, 2014 | 1.623M |
December 31, 2013 | 1.57M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 2.566M |
December 31, 2011 | 2.566M |
September 30, 2011 | 2.566M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.071M
Minimum
Dec 2019
32.29M
Maximum
Mar 2021
9.802M
Average
5.313M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
Pfizer Inc | 26.07B |
OptiNose Inc | 0.30M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |